-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 28, Dongyang Sunshine announced that its holding subsidiary, atorvastatin calcium tablets, obtained the drug registration certificate
Atorvastatin calcium is suitable for hypercholesterolemia and can reduce the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization, hospitalization due to congestive heart failure, and angina
Atorvastatin is a category B product in the 2020 edition of the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog, and it is also a cardiovascular system drug in the 2018 edition of the National Essential Medicines List